MAX
Company Analysis TRACON Pharmaceuticals, Inc.
1. Summary
Advantages
- Price (0.0322 $) is less than fair price (0.0345 $)
- The stock's return over the last year (0%) is higher than the sector average (-11.65%).
- Current debt level 9.58% is below 100% and has decreased over 5 years from 12.03%.
- The company's current efficiency (ROE=443.51%) is higher than the sector average (ROE=171.81%)
Disadvantages
- Dividends (0%) are below the sector average (0%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| TRACON Pharmaceuticals, Inc. | Index | ||
|---|---|---|---|
| 7 days | 0% | 22% | -1.3% |
| 90 days | 0% | -0.2% | -5.4% |
| 1 year | 0% | -11.6% | 16.4% |
TCON vs Sector: TRACON Pharmaceuticals, Inc. has outperformed the "" sector by 11.65% over the past year.
TCON vs Market: TRACON Pharmaceuticals, Inc. has significantly underperformed the market by -16.37% over the past year.
Stable price: TCON is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: TCON with weekly volatility of 0% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (0.0322 $) is lower than the fair price (0.0345 $).
Price not significantly lower than the fair price: The current price (0.0322 $) is slightly lower than the fair price by 7.1%.
5.2. P/E
P/E vs Sector: The company's P/E (-0.0147) is higher than that of the sector as a whole (-1333.21).
P/E vs Market: The company's P/E (-0.0147) is higher than that of the market as a whole (-88.36).
5.3. P/BV
P/BV vs Sector: The company's P/BV (-7.28) is higher than that of the sector as a whole (-179.78).
P/BV vs Market: The company's P/BV (-7.28) is lower than that of the market as a whole (81.84).
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.49) is lower than that of the sector as a whole (32.06).
P/S vs Market: The company's P/S indicator (0.49) is lower than that of the market as a whole (116.29).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0.25) is higher than that of the sector as a whole (-1765.19).
EV/Ebitda vs Market: The company's EV/Ebitda (0.25) is higher than that of the market as a whole (-79.49).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -17.5% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-17.5%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-39.35%).
6.4. ROE
ROE vs Sector: The company's ROE (443.51%) is higher than that of the sector as a whole (171.81%).
ROE vs Market: The company's ROE (443.51%) is higher than that of the market as a whole (23.33%).
6.6. ROA
ROA vs Sector: The company's ROA (-35.51%) is higher than that of the sector as a whole (-43.74%).
ROA vs Market: The company's ROA (-35.51%) is lower than that of the market as a whole (4.25%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.8%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Based on sources: porti.ru
